SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce that Willis Chandler has joined the firm’s Growth Buyout team as an Executive in Residence. Mr. Chandler will work alongside the firm to develop and execute investment strategies focused on pharma and pharmacy services.

西雅图--（商业新闻短讯）--专门专注于医疗保健行业的私募股权公司Frazier Healthcare Partners很高兴地宣布，Willis Chandler已加入该公司的成长收购团队，担任常驻高管。钱德勒将与该公司合作，制定和执行专注于制药和药房服务的投资策略。

In this role, he will focus on the sourcing, diligence, and leadership of a new platform investment for Frazier..

在这个职位上，他将专注于弗雷泽新平台投资的采购、尽职调查和领导。。

“The secular growth in pharma and pharmacy services has been an area of focus for Frazier for several years, and we are thrilled to welcome an industry veteran like Willis to our team,” said Nathan Every, General Partner at Frazier. “We are confident that his extensive leadership experience will be of great value as we partner with him to invest in this space.”.

Frazier的普通合伙人NathanEvery表示：“多年来，制药和制药服务的长期增长一直是Frazier关注的领域，我们很高兴欢迎像Willis这样的行业资深人士加入我们的团队。”。“我们相信，在我们与他合作投资这一领域时，他丰富的领导经验将非常有价值。”。

“I have long admired the way Frazier’s Growth Buyout team approaches sourcing and growing promising healthcare companies, and I am thrilled to be joining this great team,” said Mr. Chandler. “I am excited to work alongside Frazier to identify and work with disruptive growth-oriented healthcare companies.”.

钱德勒先生说：“长期以来，我一直钦佩弗雷泽的成长收购团队寻找和发展有前途的医疗保健公司的方式，我很高兴能加入这个伟大的团队。”。“我很高兴能与弗雷泽（Frazier）合作，确定并与颠覆性增长型医疗保健公司合作。”。

Mr. Chandler was most recently the President of Global Pharma Services at Cencora (NYSE: COR; f.k.a. Amerisource Bergen), where he led the multi-billion dollar business unit with 10,000 employees. Prior to his role leading the global pharma services segment, Mr. Chandler was Cencora’s President of Health System, Specialty, Government, and Commercial Solutions where he led all distribution and services into health systems and specialist facilities.

钱德勒先生最近担任Cencora（纽约证券交易所代码：COR；f.k.a.Amerisource Bergen）全球制药服务部总裁，他领导了这家拥有10000名员工的数十亿美元业务部门。在领导全球制药服务部门之前，Chandler先生曾担任Cencora的卫生系统、专业、政府和商业解决方案总裁，负责将所有分销和服务引入卫生系统和专业设施。

Prior to Cencora, Mr. Chandler was the VP of Health System Alliances at CVS Health, and before that, he was the co-founder of Shields Specialty Pharmacy, a national leader in specialty pharmacy services for hospitals and health systems. Across his roles, Mr. Chandler has a demonstrated history of entrepreneurial leadership, commercial transformation, and acquisition integration..

在加入Cencora之前，Chandler先生是CVS Health的卫生系统联盟副总裁，在此之前，他是Shields Specialty Pharmacy的联合创始人，Shields Specialty Pharmacy是医院和卫生系统专业药房服务的全国领先者。在他的各个角色中，钱德勒先生在创业领导力、商业转型和收购整合方面都有着悠久的历史。。

About Frazier Healthcare Partners:

关于Frazier Healthcare Partners：

Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 32 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies.

Frazier Healthcare Partners成立于1991年，是一家专注于医疗保健行业的私人股本公司。自成立以来，弗雷泽为私人基金和共同投资机会筹集了80多亿美元的资金，并在32年内投资了200多家公司。弗雷泽的理念是与强大的管理团队合作，同时利用其内部运营资源和网络建立卓越的公司。

Frazier is headquartered in Seattle, WA, and invests broadly across the U.S., Canada, and Europe..

弗雷泽总部位于华盛顿州西雅图，在美国、加拿大和欧洲进行广泛投资。。

For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com/home.

有关Frazier Healthcare Partners的更多信息，请访问www.frazierhealthcare.com/home。